Abdulmalik Saleh Alfawaz Altamimi

Abdulmalik Saleh Alfawaz Altamimi

Auto-generated profile, based on publicly available information

Abdulmalik Saleh Alfawaz Altamimi

Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, 11942, Saudi Arabia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2023 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
RTRiya Thapa
Riya Thapa
Obaid AfzalObaid Afzal
Obaid Afzal
ABAsif Ahmad Bhat
Asif Ahmad Bhat
AGAhsas Goyal
Ahsas Goyal
AAAbdulmalik Saleh Alfawaz Altamimi
Abdulmalik Saleh Alfawaz Altamimi
GGGaurav Gupta
Gaurav Gupta
Lung cancer is the leading cause of cancer-related deaths worldwide. Molecular profiling has contributed to a new classification of lung cancer, driving advancements in research and therapy. The at...

31 January 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
IKImran Kazmi
Imran Kazmi
MSMohammad Arshad Javed Shaikh
Mohammad Arshad Javed Shaikh
Obaid AfzalObaid Afzal
Obaid Afzal
AAAbdulmalik Saleh Alfawaz Altamimi
Abdulmalik Saleh Alfawaz Altamimi
WAWaleed H. Almalki
Waleed H. Almalki
GGGaurav Gupta
Gaurav Gupta

3 January 2024 in EXCLI Journal
Verified
Journal Article
Open access
MHMd Sadique Hussain
Md Sadique Hussain
Obaid AfzalObaid Afzal
Obaid Afzal
GGGaurav Gupta
Gaurav Gupta
AGAhsas Goyal
Ahsas Goyal
WAWaleed H. Almalki
Waleed H. Almalki
Kamal DuaKamal Dua
Kamal Dua
This review delves into the pivotal role of the long non-coding RNA NEAT1 in cancer biology, particularly in lung cancer (LC). It emphasizes NEAT1's unique subcellular localization and active involvement in gene regulation and chromatin remodeling. The review highlights NEAT1's impact on LC development and progression, including cell processes such as proliferation, migration, invasion, and resistance to therapy, positioning it as a potential diagnostic marker and therapeutic target. The complex web of NEAT1's regulatory interactions with proteins and microRNAs is explored, alongside challenges in targeting it therapeutically. The review concludes optimistically, suggesting future avenues for research and personalized LC therapies, shedding light on NEAT1's crucial role in LC.

16 March 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
Obaid AfzalObaid Afzal
Obaid Afzal
RIRizwanullah
Rizwanullah
AAAbdulmalik S.A. Altamimi
Abdulmalik S.A. Altamimi
MAManal A. Alossaimi
Manal A. Alossaimi
Mehnaz KamalMehnaz Kamal
Mehnaz Kamal
Javed AhmadJaved Ahmad
Javed Ahmad